Pharmosa Biopharm Inc. (TPEX: 6875)
Taiwan
· Delayed Price · Currency is TWD 54.30
+0.10 (0.18%)
Jan 21, 2025, 1:30 PM CST
Pharmosa Biopharm Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -292.93 | 8.46 | -266.51 | -256.48 | -181.7 | -129.63 | Upgrade
|
| Depreciation & Amortization | 26.53 | 23.32 | 12.7 | 11.79 | 10.62 | 9.85 | Upgrade
|
| Other Amortization | - | - | - | 0.01 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -13.73 | Upgrade
|
| Loss (Gain) on Equity Investments | -3.62 | -5.5 | -3.93 | -0.66 | -4.63 | 1.4 | Upgrade
|
| Stock-Based Compensation | 3.5 | 0.87 | 0.59 | 15.04 | 4 | 1.53 | Upgrade
|
| Other Operating Activities | -4.56 | - | -0.02 | -0.02 | - | - | Upgrade
|
| Change in Accounts Receivable | 18.06 | -1.18 | 0.03 | -0.14 | -0.15 | 0.02 | Upgrade
|
| Change in Inventory | -2.51 | -21.91 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | -8.31 | 0.59 | - | 2 | -0.77 | 7.6 | Upgrade
|
| Change in Other Net Operating Assets | -8.97 | 37.79 | -1.19 | -9.05 | -8.83 | -4.59 | Upgrade
|
| Operating Cash Flow | -265.57 | 42.42 | -258.31 | -237.51 | -181.45 | -127.55 | Upgrade
|
| Capital Expenditures | -189.27 | -81.46 | -10.16 | -3.06 | -7.05 | -4.27 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.38 | -0.01 | -0.03 | -0.19 | - | - | Upgrade
|
| Investment in Securities | -869 | - | - | - | - | 30.04 | Upgrade
|
| Other Investing Activities | -6.78 | -12.38 | 0.02 | 8 | 1.99 | -8.38 | Upgrade
|
| Investing Cash Flow | -1,065 | -93.84 | -10.17 | 4.75 | -5.07 | 17.4 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 161 | 157 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 9.5 | 40 | Upgrade
|
| Total Debt Issued | - | - | - | - | 170.5 | 197 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -61 | -165 | -128 | Upgrade
|
| Long-Term Debt Repaid | - | -14.22 | -15.9 | -26.34 | -33.99 | -22.82 | Upgrade
|
| Total Debt Repaid | -22.77 | -14.22 | -15.9 | -87.34 | -198.99 | -150.82 | Upgrade
|
| Net Debt Issued (Repaid) | -22.77 | -14.22 | -15.9 | -87.34 | -28.48 | 46.18 | Upgrade
|
| Issuance of Common Stock | 963.26 | 367.18 | 495.42 | 367.02 | 637.29 | 50 | Upgrade
|
| Other Financing Activities | - | - | - | - | -12 | - | Upgrade
|
| Financing Cash Flow | 940.49 | 352.97 | 479.52 | 279.68 | 596.81 | 96.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | 0 | 0.01 | - | - | - | Upgrade
|
| Net Cash Flow | -390.52 | 301.55 | 211.05 | 46.93 | 410.29 | -13.96 | Upgrade
|
| Free Cash Flow | -454.84 | -39.04 | -268.47 | -240.57 | -188.5 | -131.81 | Upgrade
|
| Free Cash Flow Margin | -900.31% | -12.41% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -3.68 | -0.34 | -2.72 | -2.83 | -3.96 | -3.54 | Upgrade
|
| Cash Interest Paid | 3.06 | 2.86 | 0.65 | 1.21 | 3.86 | 2.87 | Upgrade
|
| Levered Free Cash Flow | -369.47 | -50.37 | -165.23 | -135.95 | -127.21 | -77.62 | Upgrade
|
| Unlevered Free Cash Flow | -367.56 | -48.59 | -164.83 | -135.19 | -124.79 | -75.83 | Upgrade
|
| Change in Net Working Capital | 6.16 | -10.46 | -1.78 | -3.17 | 15.23 | -4.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.